Drug Development Market Research Reports & Industry Analysis
The drug development industry is dedicated to creating and refining treatments that improve lives and combat diseases. This field is in a state of rapid transformation, driven by advances in technology, regulatory changes, and shifting patient needs. MarketResearch.com provides hundreds of drug development industry reports to allow stakeholders to understand important market trends, challenges, and opportunities with unparalleled clarity.
Drug Development Market Research and Industry Forecasts
- Our wide-ranging reports cover a variety of dynamic markets and provide drug development market size and growth forecasts.
- Additionally, our research includes pipeline assessments of clinical trial products and clinical developments, value chain analysis, price indicators, and more.
- The competitive landscape is also covered in detail, with information on market structure, key players, company overviews, product portfolios, financials, and SWOT analyses.
MarketResearch.com: Your Dedicated Partner
Designed with consultants and busy executives in mind, our reports are powerful tools for enhancing your decision-making process. Our research can help you anticipate market changes and seize emerging opportunities as the drug development industry continues to evolve. Browse our full list of drug development market research reports to get started.
Drug Development Industry Research & Market Reports
-
MPYS protein stimulants - Pipeline Insight, 2022
... nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage MPYS ... Read More
-
HIV integrase inhibitors - Pipeline Insight, 2022
... nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage HIV ... Read More
-
Gene and Cell Therapies targeting CNS disorders - Epidemiology Forecast - 2032
... the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan ... Read More
-
Protein tyrosine phosphatase non receptor type 11 antagonists - Pipeline Insight, 2022
... landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline ... Read More
-
Spinal Cord Injury (SCI)
... the market. Every MarketVue® includes a disease overview, epidemiology (US and EU5), current treatment, unmet needs, pipeline and access and reimbursement chapter. Topics covered in this report: • Disease overview: Review the disease pathophysiology and ... Read More
-
Diabetic Retinopathy (DR)
... includes a disease overview, epidemiology (US and EU5), current treatment, unmet needs, pipeline and access and reimbursement chapter. Topics covered in this report: • Disease overview: Review the disease pathophysiology and potential druggable targets • ... Read More
-
Global Cancer Immunotherapy Market Analysis & Forecast to 2025 Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen Receptor (CAR) T-Cell Therapy, PD-1/PD-L1 inhibitors, Dendritic Cells, Checkpoint Inhibitors, Adopted Cell Therapy (ACT) & IDO Inhibitors
... (ACT) & IDO Inhibitors Within the cancer therapeutics space, which today is worth over $160 billion globally, immunotherapeutic drugs have gained worldwide acceptance. This is because they are targeted therapeutics that have high specificity for ... Read More
-
Global Biosimulation - Market and Technology Forecast to 2028
... impairment to the human body. This feature of biosimulation is extensively used while designing drugs to cure illnesses. Biosimiluation helps quantify if a drug will be harmful to the human body with regards to toxicity ... Read More
-
Outsourcing in Drug Discovery, 9th Edition
... cost-cutting strategy that can also improve the hit-to-lead conversion and early identification of unsuccessful compounds. In view of the fact that outsourcing can accelerate the drug discovery process, the business of contract drug discovery has ... Read More
-
Downstream Bioprocessing Markets (Chromatography Columns and Resins, Membrane Adsorbers, Filtration Systems, Sensors)
... plant tissue or fermentation broth. It is an essential step in producing pharmaceuticals, such as antibiotics, hormones (insulin and human growth hormone), antibodies, and vaccines. Downstream Bioprocessing Markets analyzes the current and potential world market ... Read More
-
Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 8th Edition
... 8th edition contains 2017 market size estimates and 2022 forecasts for 21 different parts of the process that might be outsourced, including: Chemistry Services Market, 2017-2022 Building Blocks Outsourcing Market, 2017-2022 Compound Synthesis Market, 2017-2022 ... Read More
Research Assistance
